Eugene Vindman (D-VA)
Cardiovascular Disease Early Detection and Prevention Act of 2026
A Democratic bill with no cosponsors
Last activity — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
What this bill would do
The bill is titled the Cardiovascular Disease Early Detection and Prevention Act of 2026. It requires group health plans, individual health insurance, and government programs like Medicare and Medicaid to cover specific cardiovascular tests. These specific tests measure lipoprotein(a) and apolipoprotein B levels. The coverage is aimed at individuals with certain health histories or risk factors, such as a family history of premature heart disease, diabetes, or obesity. Importantly, these tests must be provided without cost sharing for the patients. The changes will take effect 180 days after the bill is enacted.
Yes· 3 of 6
- Scored +7
Does this make health care easier to get in general?
By requiring group health plans, individual insurance, Medicare, and Medicaid to cover targeted cardiovascular tests without cost sharing, the bill significantly improves patient access to early heart disease detection.
- Scored +6
Does this put more money into Medicare, the health coverage for people over 65?
The bill mandates Medicare coverage for specific cardiovascular tests without any cost sharing for eligible beneficiaries.
- Scored +6
Does this put more money into Medicaid, the health coverage for people on low incomes?
The bill adds mandatory, zero-cost-sharing coverage for specific cardiovascular tests under Medicaid and benchmark plans.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Public Health Service Act Coverage: Section 3(a) amends the Public Health Service Act to require group health plans and health insurance coverage to include testing for lipoprotein(a) and apolipoprotein B levels. This is a positive outcome because it helps individuals with specific risk factors detect hidden cardiovascular risks that routine cholesterol panels often miss.
-
Medicare Coverage and No Cost Sharing: Section 3(b) amends the Social Security Act to add these specific tests to Medicare and explicitly removes cost sharing for them. This is beneficial for older Americans and individuals with disabilities who have cardiovascular risk factors, as they can get tested without paying out-of-pocket costs.
-
Medicaid Coverage and Protections: Section 3(c) amends the Social Security Act to make lipoprotein(a) and apolipoprotein B testing a mandatory, zero-cost-sharing benefit under Medicaid and benchmark coverage plans. This helps lower-income individuals and families access vital heart health screenings without financial burdens.
Potential Negative Impacts for People
- No Negative Impacts Identified: Based strictly on the provided text of the bill, there are no specific sections or provisions that outline negative consequences or burdens for individuals or groups of people in the United States.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- Healthcare
- Does this make health care easier to get in general? — By requiring group health plans, individual insurance, Medicare, and Medicaid to cover targeted cardiovascular tests without cost sharing, the bill significantly improves patient access to early heart disease detection. Does this put more money into Medicaid, the health coverage for people on low incomes? — The bill adds mandatory, zero-cost-sharing coverage for specific cardiovascular tests under Medicaid and benchmark plans. Does this put more money into Medicare, the health coverage for people over 65? — The bill mandates Medicare coverage for specific cardiovascular tests without any cost sharing for eligible beneficiaries. Does this strengthen the Affordable Care Act? — The bill amends the Public Health Service Act to require group health plans and individual health insurance to cover specific cardiovascular tests without cost sharing.
- Demographic And Interest Groups
- Would households on low incomes be better off under this? — Low-income individuals and families on Medicaid receive mandatory coverage for vital heart health screenings without out-of-pocket costs. Would people over 65 be better off under this? — Older Americans on Medicare benefit from mandatory, zero-cost coverage for crucial cardiovascular risk tests.
- 11/9/2026
- Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Introduced in House